Alterations in the cardiopulmonary effec
β
B. K. J. Leong; C. P. Sabaitis; D. A. Rop; P. Jeffrey; T. J. Parker; N. K. Burto
π
Article
π
1997
π
John Wiley and Sons
π
English
β 181 KB
π 2 views
Key words: bisphosphonate; P-450 inhibitor, pharmacokinetics; cardiopulmonary; conscious rat U-91502, a bisphosphonate for arthritic inflammation treatment, was evaluated for its parental toxicity. The objective was to differentiate between the parent drug and a reactive metabolite(s) as the proxima